Alitair gets patent for REA platform; Arrowhead acquires startup Alvos;

> Alitair announced it has received a patent allowance for REA, its ion-exchange resin-delivery platform for oral-solid drugs. Release

> Echo Therapeutics has run an operating loss since its inception, but continued development of its Prelude SkinPrep platform could help the company turn profit. More

> Arrowhead ($ARWR) has purchased the startup Alvos, bringing in the company's drug delivery tech for its RNAi treatments. Story

> Drug delivery firm Intersect ENT is quadrupling its operation size with an expansion in California. It is looking to expand production of Propel, its mometasone furoate implant for chronic sinusitis. Release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.